HemaSphere

Published by: Lippincott Williams & Wilkins  

People

  1. Salles
    Salles
  2. Rejeski
    Rejeski
  3. Shouval
    Shouval
  4. Zelenetz
    Zelenetz
  5. Zhang
    Zhang
  6. Arcila
    Arcila
  7. Baik
    Baik
  8. Bou Ayache
    Bou Ayache
  9. Chan
    Chan
  10. Chernak
    Chernak

Groups

  1. Hematologic Malignancies, Division of (19)
  2. Department of Medicine (18)
  3. Center for Hematologic Malignancies (17)
  4. Executive Committee, Center for Hematologic Malignancies (6)
  5. GSK Faculty (6)
  6. Adult Leukemia (4)
  7. Lymphoma (4)
  8. Sloan Kettering Institute Faculty (4)
  9. Immunology Program Faculty (3)
  10. Bone Marrow Transplant (2)
Search Within
Formats
  1. Journal Article (10)
  2. Editorial (4)
  3. Research Letter (4)
  4. Review (4)
  5. Correspondence (1)
  6. Guidelines (1)
Groups
  1. Hematologic Malignancies, Division of (19)
  2. Department of Medicine (18)
  3. Center for Hematologic Malignancies (17)
  4. Executive Committee, Center for Hematologic Malignancies (6)
  5. GSK Faculty (6)
  6. Adult Leukemia (4)

More Groups

People
  1. Gilles Salles (4)
  2. Marcel Van Den Brink (3)
  3. Andrew Zelenetz (2)
  4. Anthony Mato (2)
  5. Kai Rejeski (2)
  6. Roni Shouval (2)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (5)
  4. 2022 (3)
  5. 2021 (1)
  6. 2020 (4)

More Years

Publishers
  1. Lippincott Williams & Wilkins (24)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Impact of myelodysplasia-related and additional gene mutations in intensively treated patients with NPM1-mutated AML
    Journal Article

    Cocciardi, S.; Saadati, M.; Weiß, N.; Späth, D.; Kapp-Schwoerer, S.; Schneider, I.; Meid, A.; Gaidzik, V. I.; Skambraks, S.; Fiedler, W.; more...
    HemaSphere (2025)

    Fulltext@MSK | Save
  • Prognostic significance of immune reconstitution following CD19 CAR T-cell therapy for relapsed/refractory B-cell lymphoma
    Journal Article

    Stock, S.; Bücklein, V. L.; Blumenberg, V.; Magno, G.; Emhardt, A. J.; Holzem, A. M. E.; Cordas dos Santos, D. M.; Schmidt, C.; Grießhammer, S.; Frölich, L.; more...
    HemaSphere (2025)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance with multiple paraproteins: A population-based screening study
    Journal Article

    Rögnvaldsson, S.; Óskarsson, J. Þ.; Thorsteinsdóttir, S.; Hultcrantz, M.; Palmason, R.; Sverrisdottir, I. S.; Eythorsson, E.; Long, T. E.; Olafsson, I.; Thorsteinsdottir, I.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
    Journal Article

    Zelenetz, A. D.; Jurczak, W.; Ribrag, V.; Linton, K.; Collins, G. P.; Jiménez, J. L.; Bishton, M.; Dholaria, B.; Mengarelli, A.; Phillips, T. J.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Long-term survival and safety of elranatamab in patients with relapsed or refractory multiple myeloma: Update from the MagnetisMM-3 study
    Research Letter

    Tomasson, M. H.; Iida, S.; Niesvizky, R.; Mohty, M.; Bahlis, N. J.; Martinez-Lopez, J.; Koehne, G.; Rodriguez-Otero, P.; Miles Prince, H.; Viqueira, A.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of bendamustine-containing bridging therapy in R/R LBCL patients receiving CD19 CAR T-cells
    Journal Article

    Iacoboni, G.; Sánchez-Salinas, M. A.; Rejeski, K.; Martín-López, A. A.; Kwon, M.; Navarro, V.; Jalowiec, K. A.; Hernani, R.; Reguera-Ortega, J. L.; Gallur, L.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Toward a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)
    Review

    Efficace, F.; Buckstein, R.; Abel, G. A.; Giesinger, J. M.; Fenaux, P.; Bewersdorf, J. P.; Brunner, A. M.; Bejar, R.; Borate, U.; DeZern, A. E.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Comparison of whole-genome and immunoglobulin-based circulating tumor DNA assays in diffuse large B-cell lymphoma
    Research Letter

    Merryman, R. W.; Rhoades, J.; Xiong, K.; Redd, R. A.; Antel, K.; An, H. H.; McDonough, M.; Guerrero, L.; Crnjac, A.; Sridhar, S.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Myb overexpression synergizes with the loss of Pten and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemia
    Journal Article

    Almeida, A.; T'Sas, S.; Pagliaro, L.; Fijalkowski, I.; Sleeckx, W.; Van Steenberge, H.; Zamponi, R.; Lintermans, B.; Van Loocke, W.; Palhais, B.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Harnessing the gut microbiota to potentiate the efficacy of CAR T cell therapy
    Editorial

    Gabrielli, G.; Shouval, R.; Ghilardi, G.; Van Den Brink, M.; Ruella, M.
    HemaSphere (2023)

    Fulltext@MSK | Save

    • HemaSphere – authorized name for:

    Name ISSN / ISBN Publisher
    HemaSphere 2572-9241 Lippincott Williams & Wilkins
    HemaSphere 25729241 Unknown
    HemaSphere 2572-9241 Lippincott Williams & Wilkins
    HemaSphere 2572-9241 Lippincott Williams & Wilkins
    Hemasphere Wiley Blackwell
    Hemasphere Wiley Blackwell
    HemaSphere 25729241 Wolters Kluwer Health | Lippincott Williams & Wilkins
    Hemasphere Unknown